Snowball logo
logo
IOVA_logo

Iovance Biotherapeutics, Inc

IOVA β€’ NASDAQ
$13.78-$0.31Β  (2.2%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
-0.2381.189164.1263.5325
COGS
13.9821.1410.76124173.2167.7
Gross Profit
(13.98)(21.14)(9.566)40.0890.32157.3
Operating Expenses & Income
Operating Income
(342.7)(398.9)(460.6)(395.3)(398.2)(296.2)
Total Operating Expenses
342.7398.9451435.4488.5453.5
R&D Expenses
259294.8344.1282.3300.3267.7
Selling General & Admin Expenses
83.66104.127.751.8152.3149.2
Earnings from Continuing Operations
Interest Expense
(0.451)(2.985)----
Interest Income
0.4512.98511.6420.2710.317.533
Income Tax Expense
(14.43)(5.97)(3.479)(2.828)(2.071)(4.259)
Net Income
Net Income
(327.8)(389.9)(444)(372.2)(391)(289.5)
Supplemental
EBIT
(342.7)(398.9)(447.5)(375)(398.2)(296.2)
EBITDA
(328.7)(377.7)(414.4)(331.4)(350.9)(251.2)
In millions of USD, except % and values per 1 share